Previously, downregulation of TCF21 was demonstrated to be associated with poor survival in clear cell renal cell carcinoma [13], urological cancer [21], head and neck cancer [22], gastric cancer [23] and lung cancer [24]. The gene discussed is TCF21; the disease is clear cell renal carcinoma.